Curing the pandemic of misinformation on COVID-19 mRNA vaccines through real evidence-based medicine – Part 1. A doctor’s experience

By Aseem Malhotra. Excerpt from Journal of Insulin Resistance. (Link to full pdf of this peer reviewed paper is down below.)

“Another, and more useful, source of information (because of

the level of detail for each report made available to the public)

is the United States (US) Vaccine Adverse Effect Reporting

System (VAERS). As with the UK’s system, the level of

reports – including serious ones – associated with COVID-19

vaccines is completely unprecedented. For example, over

24,000 deaths have now been recorded in VAERS as of 02

March 2022; 29% of these occurred within 48h of injection, and

half within two weeks. The average reporting rate prior to

2020 was less than 300 deaths per annum. One explanation

often given for this is that the COVID-19 vaccine roll-out is

unprecedented in scope; however, this is not valid, since

(for the last decade at any rate) the United States has

administered 150 million – 200 million vaccinations annually.

Another criticism of VAERS is that ‘anyone can make an

entry’, yet, in fact, an analysis of a sample of 250 early deaths

suggested that the vast majority are hospital or physician entries,36

and knowingly filing a false VAERS report is a violation of Federal

law punishable by fine and imprisonment.”

“It has been estimated that serious adverse effects that are

officially reported are actually a gross underestimate, and this

should be borne in mind when the above comments in

relation to VAERS reports are considered. For example, a

paper by David Kessler (a former FDA Commissioner) cites

data suggesting that as few as 1% of serious adverse events

are reported to the FDA.38″

“Similarly in relation to the Yellow Card scheme in the

United Kingdom, it has been estimated that only 10%

of serious adverse effects are reported.”39 40


“It is instructive to note that according to ambulance service

data, in 2021 (the year of the vaccine roll-out), there were

approximately an extra 20,000 (~20%  increase) out-of-hospital

cardiac arrest calls compared to 2019, and approximately

14,000 more than in 2020. Data obtained under Freedom of

Information laws from one of the largest ambulance trusts in

England suggest that there was no increase from November

2020 to March 2021, and thereafter the rise has been seen

disproportionately in the young.”41

“This is a huge signal that surely needs investigating with some urgency.”42

“Similarly, a recent paper in Nature revealed a 25%  increase in

both acute coronary syndrome and cardiac arrest calls in the

16- to 39-year-old age groups significantly associated with

administration with the first and second doses of the mRNA

vaccines but no association with COVID-19 infection.43

The authors state that:

“{T]he findings raise concerns regarding vaccine-induced

undetected severe cardiovascular side effects and underscore the

already established causal relationship between vaccines and

myocarditis, a frequent cause of unexpected cardiac arrest in

young individuals. (p. 1)”

“The disturbing findings in this paper have resulted in calls

for a retraction. In the past, scientists with a different view of

how data should be analysed would have published a paper

with differing assumptions and interpretation for discussion.

Now they try to censor.”

What could be the mechanism of harm?

“For ‘conventional vaccines’, an inert part of the bacteria or

virus is used to ‘educate’ the immune system. The immune

stimulus is limited, localised and short-lived. For the COVID-19

vaccines, spike protein has been shown to be produced

continuously (and in unpredictable amounts) for at

least four months after vaccination44  and is distributed throughout the

body after intramuscular injection.45”

“For the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

vaccines, the spike protein was chosen, possibly because it enables cell

entry. However, this protein is not inert, but rather it is the

source of much of the pathology associated with severe

COVID-19, including endothelial damage,46  clotting

abnormalities 47  and lung damage. It is instructive to note that

prior to roll-out of the mRNA products, the WHO endorsed a

priority list of potential serious adverse events of special

interest that may occur as a direct result of COVID-19 vaccines.

The list was based upon the specific vaccine platform, adverse

events associated with prior vaccines in general, theoretical

associations based upon animal models and COVID-19-

specific immunopathogenesis 40  (see Figure 2).”

Is the vaccine doing more harm than good?

“The most objective determinant of whether the benefits of the

vaccines outweigh the harms is by analysing its effects on

‘all-cause mortality’. This gets round the thorny issue as to

what should be classified as a COVID-19 death, and also

takes full account of any negative effects of the vaccine. It

would be surprising – to say the least – if during an apparently

deadly pandemic, an effective vaccine could not clearly and

unequivocally be shown to reduce all-cause mortality.

Pfizer’s pivotal mRNA trial in adults did not show any

statistically significant reduction in all-cause mortality, and

in absolute terms there were actually slightly more deaths in

the treatment arm versus in the placebo.”

“Work by Fenton et al. showed an unusual spike in mortality

in each age group of the unvaccinated population, which

coincides with the vaccine roll-out for each age group.48

The rapid shrinking in the size of this population means a

small-time lag could theoretically produce this effect

artifactually. Alternative explanations must include

the (more likely) possibility that a rise in mortality after

vaccination was misattributed to the unvaccinated

population: in other words, those counted as ‘unvaccinated

deaths’ would in fact be those who had died within 14 days

of being vaccinated (a freedom of information [FOI] request

has now confirmed that authorities in Sweden were indeed

categorising deaths within 14 days of dosing as unvaccinated,

creating a misleading picture of efficacy vs death).”

“One has to raise the possibility that the excess cardiac

arrests and continuing pressures on hospitals in 2021/2022

from non-COVID-19 admissions may all be signalling a

non-COVID-19 health crisis exacerbated by interventions,

which would of course also include lockdowns and/or


“Given these observations, and reappraisal of the randomised

controlled trial data of mRNA products, it seems difficult to

argue that the vaccine roll-out has been net beneficial in all age

groups. While a case can be made that the vaccines may have

saved some lives in the elderly or otherwise vulnerable groups,

that case seems tenuous at best in other sections of the

population, and when the possible short-, medium- and

unknown longer-term harms are considered (especially for

multiple injections, robust safety data for which simply does not

exist), the roll-out into the entire population seems, at best, a

reckless gamble. It’s important to acknowledge that the risks of

adverse events from the vaccine remain constant, whereas the

benefits reduce over time, as new variants are (1)

less virulent and (2) not targeted by an outdated product. Having appraised

the data, it remains a real possibility that my father’s sudden

cardiac death was related to the vaccine. A pause and reappraisal

of vaccination Policies for  COVID-19 is long overdue.”

A 4 minute video by the M.D./researcher

<object class="wp-block-file__embed" data="; type="application/pdf" style="width:100%;height:600px" aria-label="<strong>review-study-on-effects-of-jabsreview-study-on-effects-of-jabsDownload

#Covid #SARS #CovidResponse #Covid19 #SARSCOVID-19 #mRNA #mRNAVaccines #jab #misinformation #pandemic #healthcare #mandates #governmentpolicy

About budbromley

Bud is a retired life sciences executive. Bud's entrepreneurial leadership exceeded three decades. He was the senior business development, marketing and sales executive at four public corporations, each company a supplier of analytical and life sciences instrumentation, software, consumables and service. Prior to those positions, his 19 year career in Hewlett-Packard Company's Analytical Products Group included worldwide sales and marketing responsibility for Bioscience Products, Global Accounts and the International Olympic Committee, as well as international management assignments based in Japan and Latin America. Bud has visited and worked in more than 65 countries and lived and worked in 3 countries.
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Please log in using one of these methods to post your comment: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.